Product Information

The CancerTYPE ID® test is a gene expression assay that helps physicians achieve a definitive diagnosis for metastatic patients when the tumor’s origin is uncertain. The test provides increased clarity by helping resolve the following diagnostic dilemmas that impact treatment decisions: Unclear/differential diagnoses Poorly-differentiated tumors Cancers of Unknown Primary (CUP) New cancer type vs. recurrence Unusual presentations Visit the full site for more information here.